MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$22,190,231
Prepaid clinical trial
costs
$819,721
Prepaid expenses and
other current assets
$549,684
Total current assets
$23,559,636
Total assets
$23,559,636
Total liabilities and
stockholders equity
$23,559,636
Total stockholders'
equity
$17,440,481
Total liabilities
$6,119,155
Accumulated deficit
-$187,333,939
Stockholders equity
$204,762,072
Total current
liabilities
$6,119,155
Common stock, par value
of 0.0001...
$12,348
Accrued clinical
expenses
$2,675,687
Accounts payable
$2,085,268
Other accrued
liabilities
$718,407
Accrued compensation
$408,519
Us-gaap_shorttermborrowings
$231,274
Back
Back
Balance Sheet
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
source: myfinsight.com